The pharma stock Eli Lilly (NYSE: LLY) has surged 13% higher year to date. Let's dive into Eli Lilly's fundamentals and valuation to find out. Eli Lilly reported $7.8 billion in revenue for the first quarter ended March 31, up 14.8% from the year-ago period.